Recent Company News

• 08:24 AM ET Nov 05, 2025
  

  StreetAccount Summary - US Pre-market trading

• 01:23 AM ET Nov 07, 2025
  

  StreetAccount Summary - Hong Kong equity offerings 1-Nov to 7-Nov

• 09:21 AM ET Oct 29, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 01:12 PM ET Nov 03, 2025
  

  INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of I-Mab - IMAB

• 11:16 AM ET Oct 29, 2025
  

  I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform

• 09:12 AM ET Oct 29, 2025
  

  I-Mab transitiions to NovaBridge Biosciences with name corporate name and ticker ($4.64, 0.00)

• 04:03 PM ET Oct 28, 2025
  

  I-MAB completes acquisition of Bridge Health Biotech - 6-K ($4.64, 0.00)